Fig. 4From: Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitorsForest plot of the hazard ratios of clinical outcomes of SGLT2i versus DPP4i (after PSM) among patients with T2D who had undergone PAD revascularization. Compared with DPP4i, SGLT2i were associated with comparable risks of IS, AMI, HFH, repeated revascularization, and lower limb amputation but were associated with lower risks of cardiac death and composite renal outcomes. HR hazard ratio. Other abbreviations are the same as those in Figs. 1 and 2Back to article page